MedCity News

NOVEMBER 22, 2023

Insurers and PBMs are increasingly implementing white-bagging policies, which require oncology practices to obtain physician-administered infusions and other medications from designated specialty pharmacies often owned by or affiliated with insurers and their PBMs.

Insurance 284

Insurance Physicians Patients Medical 284

MedCity News

DECEMBER 18, 2022

Many (not all) physician-/scientist-CEOs have a tendency to revert to their area of comfort by using highly scientific terminology and concepts in ways that derail from the purpose of the presentation: articulating the business case in a finite amount of meeting time.

Physicians 261

Physicians Marketing Biopharma 261

Pharmaceutical Commerce

JULY 19, 2024

In an interview with Pharma Commerce editor Nicholas Saraceno, Matthew Walsh, ixlayer’s manager of biopharma, dives into efficiencies presented by at-home diagnostic tests.

Physicians 52

Physicians Biopharma Pharma Management 52

PM360

JULY 21, 2022

As pharma reps’ access to physicians continues to decline, this case study examines the effectiveness of reaching physicians through other means—the EHR. Today’s physicians struggle to balance the increasing demands of patient loads, electronic health record (EHR) systems, and time spent on administrative tasks. THE CHALLENGE.

Physicians 52

Physicians Media Pharma sales reps Electronics 52

MedCity News

JANUARY 21, 2025

Thomas Senderovitz, senior vice president of data science at Novo Nordisk, challenges conventional notions about AI and the need for humans in the loop. The post Do We Need Humans in the Loop? A Novo Nordisk Exec Weighs In (Video) appeared first on MedCity News.

Ethics 260

Ethics Government Physicians Biopharma 260

Pharmaceutical Commerce

JULY 18, 2024

In an interview with Pharma Commerce editor Nicholas Saraceno, Matthew Walsh, ixlayer’s manager of biopharma, discusses findings of a new physician survey that the company conducted.

Biopharma 52

Biopharma Physicians Pharma Management 52

pharmaphorum

NOVEMBER 18, 2022

Physician-scientist led biotech Regeneron will be responsible for funding preclinical and clinical development and commercialisation activities, while oncology-focused biopharma CytomX will receive $30 million in an upfront payment , with the potential for up to $2 billion in research, development, regulatory, and sales-based milestones, also.

Biopharma 104

Biopharma Physicians Sales Patients 104

PM360

APRIL 22, 2024

From important changes to engaging physicians to finding out how new technologies will help address HCPs education needs, hear what our specialist had to say. What do you think are the most important changes to engaging physicians our industry needs to keep in mind now?

Education 59

Education Physicians Healthcare Healthcare 59

pharmaphorum

JANUARY 11, 2023

Roche tops biopharma partnering podium. One in five partnerships were with healthcare systems and providers, which are being “driven by a need for greater productivity and are demanding end to-end solutions that don’t require a patchwork of software solutions or apps for a single patient or physician,” says the report.

Biopharma 75

Biopharma Specialization Physicians Healthcare 75

Clarify Health

MAY 19, 2020

There is also a looming, time-sensitive reality that biopharma companies face once their products hit the market: they need to recoup the costs of development as quickly as possible before drug patents expire and generics threaten sales. Which physicians see these patients? sales, medical science liaisons, etc.).

Biopharma 52

Biopharma Physicians Marketing Patients 52

PM360

SEPTEMBER 21, 2023

This “synchronization” helps biopharmas such as Pfizer maximize marketing and field efforts across their organizations to improve engagement with healthcare professionals (HCPs). However, many biopharmas fail to synchronize engagement and digital touchpoints in a timely manner for 73% of HCPs.

Marketing 105

Marketing Media CRM Sales 105

pharmaphorum

DECEMBER 9, 2022

Nasdaq: AUTL), a clinical-stage biopharma and a portfolio company of Syncona Ltd., Autolus Therapeutic Plc.

Food and Drug Administration 98

Food and Drug Administration Safety Biopharma Patients 98

pharmaphorum

JUNE 12, 2017

Biopharma companies must take into account a multitude of factors when considering physician prescribing behaviors, and need a more integrated "pull-through" strategy across their teams, from managed markets, to marketing, to field sales.

Marketing 52

Marketing Engineering Biopharma Prescription 52

MedCity News

OCTOBER 3, 2024

The Hippocratic oath can’t stop with direct patient care; the healthcare industry and its key stakeholders must address persistent public health problems systematically. We have the tools to reduce medication harm by half or more; it is long past time to make this a public health priority.

Medical 318

Medical Healthcare Healthcare Patients 318

MedCity News

OCTOBER 24, 2024

Two chief information security officers offer some advice at a cybersecurity panel at HLTH. The post How To Spot Deepfakes and Other Cybersecurity Panel Takeaways from HLTH appeared first on MedCity News.

Physicians 318

Physicians Biopharma Healthcare Healthcare 318

MedCity News

AUGUST 21, 2024

Lifestyle is equally important for long-term success. A good behavior-change program can benefit many people with chronic conditions – whether by impacting clinical outcomes, improving quality of life, or helping to lower long-term health-care costs.

Pharmaceutical 301

Pharmaceutical Physicians Biopharma Pharma 301

MedCity News

SEPTEMBER 15, 2024

To realize true, sustainable savings in total cost of care, the healthcare system needs to reconsider the support — or lack of support — it provides throughout patients’ medication experiences and the snowball effect that creates on a lifetime of healthcare costs.

Medical 290

Medical Healthcare Healthcare Patients 290

MedCity News

SEPTEMBER 18, 2024

While fibrates are proven to lower triglyceride levels, which can serve as a biomarker for cardiovascular disease risk, several major clinical studies from the past 20 years have failed to show a benefit of fenofibrates over and above statins in further reducing heart-related events.

FDA 293

FDA Physicians Biopharma Pharma 293

Medgadget

FEBRUARY 17, 2023

Currently, the awkwardness of conventional laparoscopic tools keeps many physicians from using them in a variety of cases. ” An attractive proposition in a world in which technology has contributed significantly to the distancing of physicians from their patients, usually leading to negative side effects.

Physicians 80

Physicians Engineering Leads Side effects 80

MedCity News

DECEMBER 15, 2024

How top-to-bottom collaboration can alleviate hurdles and help increase equitable access to the most effective treatments for all cancer patients. The post Closing the Gap: Advancing Precision Oncology Through Education and Collaboration appeared first on MedCity News.

Education 284

Education Patients Medicine Physicians 284

Clarivate

APRIL 24, 2023

CVS then began affiliating with health systems across the country (like Cleveland Clinic ) for physician oversight of MinuteClinic’s staffed midlevel providers, just as Walgreens was rising as a formidable competitor in the convenient care space through its own walk-in clinics that it launched in fall 2006. Key acquisitions by U.S.

Healthcare 89

Healthcare Healthcare Marketing Physicians 89

MedCity News

NOVEMBER 13, 2023

We are on the edge of rapid innovation in psychiatry. Now is the time to break out of our silos and take advantage of the promise the future holds.

FDA 293

FDA Physicians Biopharma 293

Clarivate

JULY 5, 2023

and European physicians across six specialties, and global pipeline analysis curated by experts to provide insights into the evolving landscape. Clarivate research indicates biosimilar competition will drive down prices and relative market share of HUMIRA ® in the U.S. from 91% in 2023 to 36% by 2031.

Marketing 97

Marketing Physicians Manufacturing Competition 97

Pharma Marketing Network

MARCH 25, 2022

Members of a multidisciplinary care team may include physicians, nurses, pharmacists, radiologists, dieticians…the list goes on. Extension of the patient: expanding the role of caregivers in biopharma development. But one key member is often omitted: the patient’s caregiver. Caregiving for family and friends — a public health issue.

Pharma 98

Pharma Education Training Transportation 98

Prognos Health

FEBRUARY 1, 2022

Small and midsize pharmaceutical companies have fewer resources to dedicate to key commercialization steps such as patient and physician targeting , real-world data (RWD) curation and analysis , market share calculations, patient journey evaluations , and tracking and influencing physician prescribing behavior. Rosenorn, P. Jacquet, D.

Consulting 52

Consulting Physicians Pharma Biopharma 52

MedCity News

MARCH 7, 2023

With the rapid digitization of the entire industry and a new generation of talent waiting in the wings, Medical affairs teams need access to data and modern technology to engage with a new generation of influencers, improve diversity, and develop stronger go-to-market strategies.

Medical 274

Medical Marketing Physicians Biopharma 274

Pharmaceutical Technology

APRIL 25, 2023

The new system can be integrated with biopharma or provider-facing platforms to enable the exchange of information in real time. It aims to streamline the path-to-care process by providing greater visibility across the therapy development and delivery process for physicians and patient services teams.

Customer Relationship Management 52

Customer Relationship Management Healthcare Provider Relationship management Distribution 52

Clarivate

DECEMBER 14, 2021

2021 surveys of patients and physicians in the United States conducted by Clarivate show that: Much of care delivery has gone virtual. Three in five physicians in the United States (60%) report having conducted virtual consultations, as do 35% of patients. physicians; Source: Clarivate, Taking the Pulse(R) U.S.

Pharma 52

Pharma Healthcare Healthcare Physicians 52

The Marketing Advantage

MAY 8, 2023

Long/Difficult Road to Diagnosis It often takes years and several physicians to reach a diagnosis Knowing the types of physicians that patients are likely to see on their road to diagnosis means companies can pursue those physicians to drive early diagnosis and treatment.

Sales 52

Sales Physicians Consulting Education 52

Impetus Digital

AUGUST 10, 2023

Last but not least, for smaller biopharma companies especially, the high cost of organizing a single in-person advisory board can make ongoing insight-gathering difficult.

Pharmaceutical 95

Pharmaceutical Transportation Food Biopharma 95

MedCity News

MAY 16, 2023

As we consider the ramifications of the President’s cancellation of the Pandemic emergency, we have time to reflect on the transformation of the 3 P’s of healthcare: People, Policies and Politics.

Healthcare 246

Healthcare Healthcare Physicians Biopharma 246

MedCity News

JUNE 20, 2023

Biosimilars represent an important therapeutic option in modern healthcare, offering cost-effective alternatives to complex biological drugs. The educational gap among healthcare professionals poses a challenge to their widespread adoption. Medical Affairs teams in the pharmaceutical industry are at the forefront of bridging this gap

Education 243

Education Healthcare Healthcare Medical 243

pharmaphorum

SEPTEMBER 12, 2022

Dr Prasanth Reddy, head of oncology at LabCorp, tells us how the company works with cancer care teams, biopharma partners, and patients as an integral part of the patient journey from testing to treatment. He holds a master’s degree in public health, is a Harvard Business School alumnus, and serves as an American College of Physicians fellow.

Patients 105

Patients Medicine FDA Healthcare 105

pharmaphorum

OCTOBER 18, 2022

It will create a Nasdaq-listed biopharmaceutical company under the name “Oculis Holding SA”, placing Oculis in position to become a leading global ophthalmic biopharma, with product candidates to address areas of significant medical needs affecting a growing number of patient populations.

Biopharma 59

Biopharma Management Specialization Physicians 59

Clarivate

MARCH 12, 2024

For the approximately 10% of biopharma candidates that actually manage to make it to clinical trials, many fail to achieve enough revenue once they reach the market to justify the R&D effort. In fact, one-third of drugs launched over a recent 10-year period fell short of sales expectations.

Government 52

Government Marketing Physicians Biopharma 52

PM360

MAY 21, 2024

sarah.caldwell@veeva.com SARAH CALDWELL General Manager Veeva Crossix Analytic Consumers’ TV viewing habits are changing, and streaming video continues to catapult in popularity, unearthing new opportunities for biopharma advertisers to reach patients in more targeted ways. According to Nielsen, streaming accounts for 38% of viewership hours.

Media 105

Media Healthcare Healthcare Marketing 105

MedCity News

DECEMBER 16, 2022

Clinical research as a care option is a means of connecting patients with clinical research as part of their ongoing health care, located where they receive that care, and offered by their trusted provider.

Patients 246

Patients Physicians Biopharma 246